These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 8917180
41. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R, Even-Sapir E, Chisin R, Israel O. World J Surg; 2006 Jan; 30(1):76-83. PubMed ID: 16369710 [Abstract] [Full Text] [Related]
43. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123. Hindié E, Mellière D, Jeanguillaume C, Perlemuter L, Chéhadé F, Galle P. J Nucl Med; 1998 Jun; 39(6):1100-5. PubMed ID: 9627353 [Abstract] [Full Text] [Related]
44. Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism. Yeh R, Tay YD, Tabacco G, Dercle L, Kuo JH, Bandeira L, McManus C, Leung DK, Lee JA, Bilezikian JP. Radiology; 2019 May; 291(2):469-476. PubMed ID: 30835187 [Abstract] [Full Text] [Related]
45. Presurgical localization of abnormal parathyroid glands using a single injection of technetium-99m methoxyisobutylisonitrile: comparison of different techniques including factor analysis of dynamic structures. Blocklet D, Martin P, Schoutens A, Verhas M, Hooghe L, Kinnaert P. Eur J Nucl Med; 1997 Jan; 24(1):46-51. PubMed ID: 9044876 [Abstract] [Full Text] [Related]
52. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism. Araz M, Soydal Ç, Özkan E, Kir MK, İbiş E, Güllü S, Erdoğan MF, Emral R, Küçük ÖN. Nucl Med Commun; 2018 Nov; 39(11):989-994. PubMed ID: 30138157 [Abstract] [Full Text] [Related]
53. Cost utility of routine imaging with Tc-99m-sestamibi in primary hyperparathyroidism before initial surgery. Wei JP, Burke GJ. Am Surg; 1997 Dec; 63(12):1097-100; discussion 1100-1. PubMed ID: 9393259 [Abstract] [Full Text] [Related]
54. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944 [Abstract] [Full Text] [Related]
55. Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Wong KK, Fig LM, Gross MD, Dwamena BA. Nucl Med Commun; 2015 Apr; 36(4):363-75. PubMed ID: 25642803 [Abstract] [Full Text] [Related]
56. The role of contrast-enhancend ultrasonography (CEUS) in comparison with 99mTechnetium-sestamibi scintigraphy for localization diagnostic of primary hyperparathyroidism. Agha A, Hornung M, Schlitt HJ, Stroszczynski C, Jung EM. Clin Hemorheol Microcirc; 2014 Apr; 58(4):515-20. PubMed ID: 24165576 [Abstract] [Full Text] [Related]